Board Consulting Agreement Sample Contracts

ADVISORY BOARD CONSULTING AGREEMENT (Between) PROF. DR. MED. MICHAEL OTT (And) HEPALIFE TECHNOLOGIES, INC. July 8, 2004
Board Consulting Agreement • June 12th, 2007 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus • Florida

THIS HEPALIFE TECHNOLOGIES, INC., ADVISORY BOARD CONSULTING AGREEMENT (this “Agreement”) is made effective as of July 8, 2004 (the “Effective Date”), by and between HepaLife Technologies, Inc., a Florida corporation (the “Company” or “HepaLife”) and Prof. Dr. med. Michael Ott, an individual acting as an independent contractor to the Company (“Consultant”).

AutoNDA by SimpleDocs
ADVISORY BOARD CONSULTING AGREEMENT (Between) MR. FRANK MENZLER, D.ING, MBA (And) HEPALIFE TECHNOLOGIES, INC. June 4, 2004
Board Consulting Agreement • January 24th, 2006 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus • Florida

THIS HEPALIFE TECHNOLOGIES, INC., ADVISORY BOARD CONSULTING AGREEMENT (this “Agreement”) is made effective as of June 4, 2004 (the “Effective Date”), by and between HepaLife Technologies, Inc., a Florida corporation (the “Company” or “HepaLife”) and Mr. Frank Menzler, an individual acting as an independent contractor to the Company (“Consultant”).

ADVISORY BOARD CONSULTING AGREEMENT
Board Consulting Agreement • November 2nd, 2011 • Max Sound Corp • Services-computer processing & data preparation • California

This MAX SOUND ADVISORY BOARD CONSULTING AGREEMENT is made effective as of October 4, 2011 (the "Effective Date"), by and between CARL STUBNER, (the consultant), an individual acting as an independent contractor, and MAX SOUND, INC., a Delaware corporation (the "Company").

CYTOKINETICS, INC. SCIENTIFIC ADVISORY BOARD CONSULTING AGREEMENT
Board Consulting Agreement • April 2nd, 2008 • Cytokinetics Inc • Pharmaceutical preparations • California

This Consulting Agreement (the “Agreement”) is made and effective as of April 1, 2008 (the “Effective Date”), by and between Cytokinetics, Inc. (the “Company”) and James H. Sabry, M.D., Ph.D., an individual (“Consultant”).

ADVISORY BOARD CONSULTING AGREEMENT
Board Consulting Agreement • November 22nd, 2022 • Becton Dickinson & Co • Surgical & medical instruments & apparatus

This Advisory Board Consulting Agreement (“Agreement”) is made and entered into on October 31, 2022 (“Effective Date”), by and between Becton, Dickinson and Company, a New Jersey corporation with an address at One Becton Drive, Franklin Lakes, NJ 07417 (“BD”), and Claire M. Fraser, with an address of [***] (“Consultant”) (each of BD and Consultant being a “party” and collectively, the “parties”).

SCIENTIFIC ADVISORY BOARD CONSULTING AGREEMENT
Board Consulting Agreement • November 15th, 1999 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
BOARD CONSULTING AGREEMENT
Board Consulting Agreement • May 2nd, 2012 • Unum Group • Accident & health insurance • Delaware

THIS BOARD CONSULTING AGREEMENT (this "Agreement") is entered into as of the 16th day of April, 2012, by and between Unum Group, a Delaware corporation having its principal executive offices in Chattanooga, Tennessee (the "Company"), and Robert O. Best (the "Consultant").

ADVISORY BOARD CONSULTING AGREEMENT
Board Consulting Agreement • June 12th, 2007 • Hepalife Technologies Inc • Surgical & medical instruments & apparatus • Massachusetts

THIS HEPALIFE TECHNOLOGIES, INC., ADVISORY BOARD CONSULTING AGREEMENT (“Agreement”) is made effective as of June 1, 2007 (“Effective Date”), by and between HepaLife Technologies, 60 State Street, Suite 700, Boston, MA 02109 (“HepaLife”) and Paul Coussens, Ph.D., 511 Westmoreland, Lansing, MI 48915, an individual acting as an independent contractor to HepaLife (“Consultant”).

Re: SpineMedica Physician Advisory Board Consulting Agreement Dear Dr. DeWald:
Board Consulting Agreement • June 27th, 2008 • Mimedx Group, Inc. • Surgical & medical instruments & apparatus • Georgia

SpineMedica Corp., (“SpineMedica” or “the Company”) hereby confirms its mutual agreement with you to serve as a consultant to the Company by serving as a member of the Company’s Physician Advisory Board (“PAB”) upon the terms and conditions set forth in this letter agreement within the field of spinal disc replacement involving the proprietary Salubria™ material exclusively licensed to the Company in the all spinal applications, including the development, production and sale of SaluDisc™ spinal disc prostheses (“Field”) and with respect to the Company’s other research, development, and business activities. The Field of this agreement may be broadened by mutual consent.

Time is Money Join Law Insider Premium to draft better contracts faster.